doi:10.3969/j.issn.1673-8640.2024.09.018

Abstract

CLC Number:

R446.1

Figures/Tables 5

References 16

[1]	American Diabetes Association. 2. Classification and diagnosis of diabetes:standards of medical care in diabetes-2021[J]. Diabetes care, 2021, 44(9):2182.
[2]	张军, 李彩娜, 陈歆琦, 等. 血红蛋白毛细管采集系统贮存血样用于测定糖化血红蛋白的稳定性研究[J]. 中国临床药理学杂志, 2019, 35(6):567-570.
[3]	EZENWAKA C E, SEALES D, SURUJLAL R, et al. Glycated haemoglobin A1c measurement in stored whole blood sample is reliable for clinical use[J]. West Indian Med J, 2009, 58(1):17-20.
[4]	YANG X, ZENG X, ZHANG Y, et al. Evaluation of interference from 16 hemoglobin variants on hemoglobin A1c measurement by five methods[J]. Scand J Clin Lab Invest, 2023, 83(1):18-22.
[5]	TANGHERONI W, ZORCOLO G, GALLO E, et al. Haemoglobin J Sardegna:alpha50(CD 8)histidine→aspartic acid[J]. Nature, 1968, 218(5140):470-471.
[6]	MANCA L, MASALA B. Identification of Hb J-sardegna [alpha50(CE8)His→Asp] by HPLC and its incidence in northern Sardinia[J]. Hemoglobin, 1989, 13(1):33-44.
[7]	王荷碧, 赵香文, 罗爱贞, 等. 我国异常血红蛋白的研究-Hb J Sardegna及Hb G San-Jose的一级结构[J]. 天津医药, 1988(7):410-412.
[8]	CORDA M, DE ROSA M C, PELLEGRINI M G, et al. Adult and fetal haemoglobin J-Sardegna [alpha50(CE8)His→Asp]:functional and molecular modelling studies[J]. Biochem J, 2000, 346(Pt 1):193-199.
[9]	GALLO E, PUGLIATTI L, RICCO G, et al. A case of haemoglobin J sardegna/β-thalassaemia double heterozygosis[J]. Acta haematol, 1972, 47(5):311-320.
[10]	PISTIDDA P, GUISO L, FROGHERI L, et al. The homozygous state of Hb J Sardegna[J]. Hematol J, 2002, 3(4):176-178. PMID
[11]	CHEN Z, SHAO L, JIANG M, et al. Interpretation of HbA1c lies at the intersection of analytical methodology,clinical biochemistry and hematology(review)[J]. Exp Ther Med, 2023, 25(4):186.
[12]	XU A, CHEN W, XU M, et al. Identification of hemoglobin variants prevalent in China and their effects on hemoglobin A1c measurements[J]. Am J Clin Pathol, 2022, 157(6):852-857.
[13]	YANG X, ZENG X, ZHANG Y, et al. Evaluation of interference from 16 hemoglobin variants on hemoglobin A1c measurement by five methods[J]. Scand J Clin Lab Invest, 2023, 83(1):18-22.
[14]	RATNAM C, YEN TRAN HOUANGKEO T H, MOUTEREAU S, et al. Effect of hemoglobin N baltimore on HbA1c measurement in six methods[J]. Ann Biol Clin(Paris), 2019, 77(2):155-159.
[15]	ROHLFING C, HANSON S, ESTEY M P, et al. Evaluation of interference from hemoglobin C,D,E and S traits on measurements of hemoglobin A1c by fifteen methods[J]. Clin Chim Acta, 2021,522:31-35.
[16]	周翔海, 纪玲, 纪立农, 等. 影响糖化血红蛋白临床应用的血红蛋白变异体识别的专家共识[J]. 中国糖尿病杂志, 2023, 31(8):561-570.

基因	正向引物（5'~3'）	反向引物（5'~3'）
α1	TCCCCACAGACTCAGAGAGAACC	CCATGCCTGGCACGTTTGCTGAG
α2	TCCCCACAGACTCAGAGAGAACC	AACACCTCCATTGTTGGCACATTCC
β1	CTAGGGTTGGCCAATCTACTC	GCAATCATTCGTCTGTTTCC
β2	AAGGCTGGATTATTCTGAGTC	TGTATTTTCCCAAGGTTTGA
γ	CAAATATCTGTCTGAAACGGTC	TATCTTCAAACAGCTCACACCC
δ	TAGCAACCTCAAACAGACACCA	GGAAACAGTCCAGGATCTCAAT

基因	正向引物（5'~3'）	反向引物（5'~3'）
α1	TCCCCACAGACTCAGAGAGAACC	CCATGCCTGGCACGTTTGCTGAG
α2	TCCCCACAGACTCAGAGAGAACC	AACACCTCCATTGTTGGCACATTCC
β1	CTAGGGTTGGCCAATCTACTC	GCAATCATTCGTCTGTTTCC
β2	AAGGCTGGATTATTCTGAGTC	TGTATTTTCCCAAGGTTTGA
γ	CAAATATCTGTCTGAAACGGTC	TATCTTCAAACAGCTCACACCC
δ	TAGCAACCTCAAACAGACACCA	GGAAACAGTCCAGGATCTCAAT

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 16

Related Articles 15

Recommended Articles

Metrics

[1]	GUO Yuanyuan, SONG Hui, ZHANG Lin. Relationship between FANCF/BRCA1 protein expression and treatment response in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2024, 39(10): 1005-1009.
[2]	CUI Weiqi, OU Xinyang, ZHAO Chunhe, XIA Wei, QU Linlin. Progress of thrombin-activatable fibrinolysis inhibitor determination in clinical application [J]. Laboratory Medicine, 2024, 39(10): 1021-1026.
[3]	ZHU Longyin, PAN Qianguang, YANG Sha, ZENG Yuqin, FU Chunxiao, PU Youmin, FANG Jia, YAN Chunyan, ZHAO Hongwen. Early warning value of whole blood cell derived inflammatory markers for delayed graft function of renal transplantation [J]. Laboratory Medicine, 2024, 39(10): 939-944.
[4]	ZHANG Caili, LUO Xiaohua, YANG Peifeng, LIU Pengli, REN Fang. Prognostic roles of serum FGF2 and FGFR1 in preeclampsia [J]. Laboratory Medicine, 2024, 39(10): 945-949.
[5]	HUANG Qian, SHEN Qin, HU Qiuyun, SUN Jing, WAN Pingyin. Predictive values of serum CTRP3 and DKK-1 levels for the occurrence of fractures in postmenopausal osteoporosis patients [J]. Laboratory Medicine, 2024, 39(10): 950-955.
[6]	LEI Ming, ZHAI Li, WEI Ying, LIN Yichen, GUO Mengyue. Application of nomogram model based on clinical characteristics and serum tumor markers in differential diagnosis of benign and malignant lung lesions [J]. Laboratory Medicine, 2024, 39(10): 956-962.
[7]	TIAN Na, CHEN Shihong, YANG Tao. Correlation between serum METRNL，sTREM-1 levels and carotid atherosclerosis in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2024, 39(10): 963-968.
[8]	LI Yanhua, LI Kuo, JI Chunxue, WANG Lixuan, HUANG Shaoyue, GUO Jian, LI Dongxu. Relationship between serum amyloid beta，chitinase 3-like protein 1 levels and carotid artery lesions in patients with ischemic cerebrovascular disease [J]. Laboratory Medicine, 2024, 39(9): 823-827.
[9]	LOU Zhan, PENG Tao, LIU Xingliang, YUE Binghong, LI Ran, ZHI Yongyi. Changes of serum NFL，Cys C and Lp-PLA2 levels in patients with vascular Parkinsonism and their clinical significance [J]. Laboratory Medicine, 2024, 39(9): 828-833.
[10]	LI Kun, HU Bingtao, WAN Nan. Roles of serum irisin and soluble Corin in prognosis assessment of elderly patients with chronic heart failure [J]. Laboratory Medicine, 2024, 39(9): 834-840.
[11]	FANG Huiling, JU Yi, OU Yuanzhu, ZHU Yuqing, LI Qing, JIN Zhonggan, ZHAO Xiaojun, FAN Xiaoyu, YU Keying. Current status of liquid chromatography-tandem mass spectrometry in clinical laboratories in Shanghai [J]. Laboratory Medicine, 2024, 39(9): 853-858.
[12]	WANG Xiaomei, LUO Chao, TIE Yang, HE Yong, YANG Xikui, LIU Yalin, SUN Yue, WANG Fugang, HE He. Application of random urine uric acid/creatinine in classification of hyperuricemia patients in Karamay [J]. Laboratory Medicine, 2024, 39(9): 859-864.
[13]	LI Menghan, HE Xiaofei, ZHANG Qiong, ZHOU Yu. Change trend of fasting plasma glucose of healthy subjects in a Grade 3A hospital in Beijing from 2012 to 2023 [J]. Laboratory Medicine, 2024, 39(9): 865-870.
[14]	WANG Hao, XIA Wenying, TONG Wei, WU Wenjia. Level change and clinical significance of serum lipoprotein-associated phospholipase A2 in patients with depression [J]. Laboratory Medicine, 2024, 39(9): 871-874.
[15]	QUAN Rongrong, WANG Min. Prognostic value of serum IL-2，IL-6，IL-8 and IL-10 in patients with irritable bowel syndrome [J]. Laboratory Medicine, 2024, 39(9): 875-879.